Stem cell research moves in stages. Scientists study cells in the lab, then in animals, and only after that do they run small studies in people, followed by larger ones. Each stage asks a different question, and a published study or a study listing tells you which stage it is in.
Reading that label correctly is the most useful skill for anyone who follows stem cell news. This article walks through each stage, explains study phases in plain language, and shows how to read a study listing.
Stage 1: the lab study
Research starts with a question about how cells behave. In the lab, researchers grow stem cells in dishes and watch what they do: how they copy themselves, which signals they respond to and which specialized cells they produce. (The background is in what stem cells are.)
A lab study answers "what happens in a dish?" It does not answer what happens in a person, and it is not meant to.
Stage 2 of stem cell research: studies in animals
If lab work holds up, researchers often move to animal studies. These ask whether the cells behave the same way inside a living body, and what the early safety picture looks like. This stage is called preclinical research, because no people are involved yet.
Animal results guide the next step. They are not a forecast for people, and researchers say so in their papers.
Stage 3 of stem cell research: studies in people
A study in people runs under a written plan called a protocol. The protocol says who can join, what is given, what is measured and how long people are followed. These studies usually run in phases.
| Phase | Group size | The question it asks |
|---|---|---|
| Phase 1 | Small | Is it safe, and what dose can people tolerate? |
| Phase 2 | Larger | What dose to use, and are there early signals worth testing further? |
| Phase 3 | Large | How does it compare with a control group or a standard approach? |
| Phase 4 | Broad | What is seen once a product is approved and in wider use? |
Not every study passes through every phase, and not every product reaches Phase 3. A Phase 1 result and a Phase 3 result mean very different things, which is why the phase belongs in any summary.
Words you will meet
- Randomized. Participants are assigned to groups by chance.
- Placebo-controlled. One group receives an inactive product so the groups can be compared.
- Double-blind. Neither participants nor researchers know who is in which group until the end.
- Peer-reviewed. Independent experts reviewed the paper before it was published.
How to read a stem cell study listing
Public studies are listed on ClinicalTrials.gov, the registry run by the U.S. National Library of Medicine. A listing is a short, structured summary, and a few fields tell you most of what you need.
- Status. Recruiting, active, completed or withdrawn. Status tells you where the study stands today.
- Phase. Phase 1 through 4, as described above.
- Sponsor and locations. Who runs the study and where.
- Eligibility. Who can join. This describes the people being studied, not everyone.
- Design. Randomized or not, placebo or comparison group, how many participants.
- What is measured. The listed measures show what the researchers set out to learn.
A listing describes a plan. A completed study's results are reported separately, in a paper or in the registry's results section, and a careful reader checks the paper rather than a headline.
Questions to ask of any study you read about
- Which stage is this, a lab study, an animal study or a study in people?
- How many people took part?
- Was there a comparison group?
- Did independent experts review it?
- Who paid for it?
- Does it study the same kind of cells you are reading about?
The last question matters more than it sounds. Research on one kind of cell, such as blood-forming cells, says little about a different kind.
What a stem cell study is and what a stem cell therapy visit is
A study follows a protocol set by researchers, and its purpose is to answer a question. A visit at a wellness center is something else: a service planned between you and a licensed provider.
At GIOSTAR, stem cell therapy and exosome therapy are self-pay services. You start with a free consultation with our patient team, then meet a nurse practitioner who reviews your history and gives you the full total before you book. GIOSTAR International is part of a network built on research at Salk, UC San Diego, UC Irvine and UCLA.
Where to go next with stem cell and regenerative medicine
Start with what regenerative medicine is for the field as a whole, then what stem cell therapy is for how the service works at our center. You can also read about regenerative medicine at GIOSTAR.
Regenerative medicine at GIOSTAR in Henderson
GIOSTAR stands for Global Institute of Stem Cell Therapy and Research. Our Henderson wellness center, now open at 2482 W. Horizon Ridge Pkwy, Ste 100, offers stem cell therapy and exosome therapy, and Dr. Ryan Peterson, our Medical Director, oversees care. Start with a free consultation with our patient team, with no obligation.
